Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMI3YLK)

Drug Name

LA-EP2006 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Neutropenia	4B00.0	Phase 3	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Granulocyte colony-stimulating factor (CSF3)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Eflapegrastim	DMACVEI	Neutropenia	4B00.0	Approved	[3]
Efbemalenograstim	DMDNJ18	Neutropenia	4B00.0	Approved	[4]
Interleukin-3	DM1Y69Q	Aplastic anemia	3A70	Approved	[5]
Neugranin	DMLRKJX	Neutropenia	4B00.0	Preregistration	[6]
DA-3031	DM6S4R2	Neutropenia	4B00.0	Phase 3	[7]
MK-4214	DMA25NO	Neutropenia	4B00.0	Phase 3	[8]
------------------------------------------------------------------------------------


⏷ Show the Full List of 6 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Granulocyte colony-stimulating factor (CSF3)	TT5TQ2W	CSF3_HUMAN	Modulator	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01516736) Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim. U.S. National Institutes of Health.
2	National Cancer Institute Drug Dictionary (drug id 724518).
3	Company report (Sppirx)
4	Clinical pipeline report, company report or official report of Generon (Shanghai) Corporation Ltd.
5	Interleukin 3: from colony-stimulating factor to pluripotent immunoregulatory cytokine. Int J Immunopharmacol. 1992 Apr;14(3):421-30.
6	Development and Characterization of a Novel Fusion Protein of a Mutated Granulocyte Colony-Stimulating Factor and Human Serum Albumin in Pichia pastoris. PLoS One. 2014; 9(12): e115840.
7	A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer.Invest New Drugs.2013 Oct;31(5):1300-6.
8	DOI: 10.1038/nbt0710-636a